Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs Frontiers Stable Gastric Pentadecapeptide BPC 157 and Wound Healing